Advertisement

Pharmacological Significance of Pre- and Postsynaptic Dopamine Receptors

  • Salomon Z. Langer
  • Sonia Arbilla
Part of the New Horizons in Therapeutics book series (NHTH)

Abstract

Stimulation of dopamine receptors of the D-2 subtype reduces the release of various neurotransmitters in the peripheral and central nervous systems (for reviews, see Langer, 1980; Langer and Lehmann, 1984).

Keywords

Dopamine Receptor Acetylcholine Release Dopamine Receptor Agonist Dopamine Receptor Antagonist Striatal Slice 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Angrist, B. M., and Gershon, S., 1970, The phenomenology of experimentally induced amphetamine psychosis. Preliminary observations, Biol. Psychiatry 2:95–107.PubMedGoogle Scholar
  2. Arbilla, S., and Langer, S. Z., 1981, Stereoselectivity of presynaptic autoreceptors modulating dopamine release, Eur. J. Pharmacol. 76:345–351.PubMedCrossRefGoogle Scholar
  3. Arbilla, S., and Langer, S. Z., 1983, Blockade by (-)3PPP of the dopamine receptors that modulate the release of 3H-acetylcholine in rat striatal slices, Br. J. Pharmacol. 79:193.Google Scholar
  4. Arbilla, S., Kamal, L., and Langer, S. Z., 1981, Inhibition by apomorphine of the potassiumevoked release of 3H-γ-aminobutyric acid from the rat substantia nigra in vitro, Br. J. Pharmacol. 74:389-397.Google Scholar
  5. Armstrong, J. M., Duval, N., and Langer, S. Z., 1982, Possible heterogeneity of dopamine receptors in coronary vascular smooth muscle of the anaesthetised dog, Br. J. Pharmacol. 77:471P.Google Scholar
  6. Armstrong, J. M., Duval, N. and Langer, S. Z., 1983, LY 141865 stimulates histamine-2 (H2) receptors and dopamine-2 (DA2) receptors in the anaesthetised dog, Eur. J. Pharmacol. 87:165–166.PubMedCrossRefGoogle Scholar
  7. Armstrong, J. M., Duval, N., and Langer, S. Z., 1984, Characterization of the postsynaptic receptors mediating dilatation of the coronary vascular bed produced by dopamine-like agents in anesthetized dogs, Naunyn Schmiedebergs Arch. Pharmacol. (in press).Google Scholar
  8. Cantrill, R., Arbilla, S., and Langer, S. Z., 1983a, Inhibition by d-amphetamine of the electrically-evoked release of 3H-acetylcholine from slices of the rat striatum: Involvement of dopamine receptors, Eur. J. Pharmacol. 87:167–168.CrossRefGoogle Scholar
  9. Cantrill, R., Arbilla, S., Zivkovic, B., and Langer, S. Z., 1983b, Amphetamine enhances latent dopaminergic neurotransmission in the rat striatum: effects on 3H-acetylcholine release, Naunyn Schmiedebergs Arch. Pharmacol. 322:322–324.CrossRefGoogle Scholar
  10. Choi, R. L., and Roth, R. H., 1978, Development of supersensitivity of apomorphine induced increases in acetylcholine levels and stereotypy after chronic fluphenazine treatment, Neuropharmacology 17:59–64.PubMedCrossRefGoogle Scholar
  11. Costall, B., Lim, S. K., and Naylor, R. J., 1981, Characterisation of the mechanisms by which purported dopamine agonists reduce spontaneous locomotor activity of mice, Eur. J. Pharmacol. 73:175–188.PubMedCrossRefGoogle Scholar
  12. DiChiara, G., Porceddu, M. L., Vargin, L., Stefanini, E., and Gessa, G. L., 1976, Evidence for dopamine receptors mediating sedation in the mouse brain, Nature 264:564–567.CrossRefGoogle Scholar
  13. Dubocovich, M. L., and Langer, S. Z., 1974, Negative feed-back regulation of noradrenaline release by nerve stimulation in the perfused cat’s spleen: Differences in potency of phenoxybenzamine in blocking the pre-and post-synaptic adrenergic receptors, J. Physiol. (Lond.) 237:505–519.Google Scholar
  14. Dubocovich, M. L., and Langer, S.Z., 1976, Influence of the frequency of nerve stimulation on the metabolism of 3H-norepinephrine released from the perfused cat spieen: Differences observed during and after the period of stimulation, J. Pharmacol. Exp. Ther. 198:83–101.PubMedGoogle Scholar
  15. Dubocovich, M. L., and Langer, S. Z., 1980, Dopamine and alpha-adrenoceptor agonists inhibit neurotransmission in the cat spieen through different presynaptic receptors, J. Pharmacol. Exp. Ther. 212:144–152.PubMedGoogle Scholar
  16. Enero, M. A., and Langer, S. Z., 1975, Inhibition by dopamine of 3H-noradrenaline release elicited by nerve Stimulation in the isolated cat’s nictitating membrane, Naunyn Schmiedebergs Arch. Pharmacol. 289:179–203.PubMedCrossRefGoogle Scholar
  17. Feltz, P., and De Champlain, J., 1973, The postsynaptic effects of amphetamine on striatal dopamine-sensitive neurons, in: Frontiers in Catecholamine Research, Pergamon Press, Oxford, pp. 951–956.Google Scholar
  18. Galzin, A. M., Dubocovich, M. L., and Langer, S. Z., 1982, Presynaptic inhibition by dopamine receptor agonists of noradrenergic neurotransmission in the rabbit hypothalamus, J. Pharmacol. Exp. Ther. 221:461–471.PubMedGoogle Scholar
  19. Garau, L., Govoni, S., Stefanini, E., and Spano, P. F., 1978, Dopamine receptors: Pharmacological and anatomical evidences indicate that two distinct dopamine receptor populations are present in rat striatum, Life Sci. 23:1745–1750.PubMedCrossRefGoogle Scholar
  20. Goldberg, L. I., 1979, The dopamine vascular receptor: Agonists and antagonists. Advances in Biosciences: Peripheral Dopaminergic Receptors, Volume 20 (J. L. Imbs and J. Schwartz, eds.), Pergamon Press, Oxford, pp. 1–12.Google Scholar
  21. Goldberg, L. I., and Kohli, J. D., 1983, Peripheral dopamine receptors: A classification based on potency series and specific antagonism, Trends Pharmacol. Sci. 4:64–66.CrossRefGoogle Scholar
  22. Hertting, G., Zumstein, A., Jackisch, R., Hoffmann, L, and Starke, K., 1980, Modulation by endogenous dopamine of the release of acetylcholine in the caudate nucleus of the rabbit, Naunyn Schmiedebergs Arch. Pharmacol. 315:111–117.PubMedCrossRefGoogle Scholar
  23. Jenner, P., and Marsden, C. D., 1981, Substitute benzamide drugs as selective neuroleptic agents, Neuropharmacology 20:1285–1293.PubMedGoogle Scholar
  24. Jönsson, L. E., Ånggard, E., and Gunne, L. M., 1971, Blockade of intravenous amphetamine euphoria in man, Clin. Pharmacol. Ther. 12:889–896.PubMedGoogle Scholar
  25. Kamal, L., Arbilla, S., and Langer, S. Z., 1981, Presynaptic modulation of the release of dopamine from the rabbit caudate nucleus: Differences between electrical stimulation, amphetamine and tyramine, J. Pharmacol. Exp. Ther. 216:592–598.PubMedGoogle Scholar
  26. Kebabian, J. W., and Calne, D. B., 1979, Multiple receptors for dopamine, Nature 277:93–96.PubMedCrossRefGoogle Scholar
  27. Langer, S. Z., 1973, The regulation of transmitter release elicited by nerve Stimulation through a presynaptic feed-back mechanism, in: Frontiers in Catecholamine Research (E. Usdin and S. Snyder, eds.), Pergamon Press, Oxford, New York, pp. 543–549.Google Scholar
  28. Langer, S. Z., 1981, Presynaptic regulation of the release of catecholamines, Pharmacol. Rev. 32:337–362.Google Scholar
  29. Langer, S. Z., and Dubocovich, M. L., 1979, Physiological and pharmacological role of the regulation of noradrenaline release by presynaptic dopamine receptors, in: Peripheral Dopamine Receptors (J. L. Imbs and J. Schwartz, eds.), Pergamon Press, Oxford, New York, pp. 233–245.Google Scholar
  30. Langer, S. Z., and Dubocovich, M. L., 1981, Cocaine and amphetamine antagonize the decrease of noradrenergic transmission elicited by oxymetazoline but potentiate the inhibition by a-methylnorepinephrine in the perfused cat spleen, J. Pharmacol. Exp. Ther. 216:162–171.PubMedGoogle Scholar
  31. Langer, S. Z., and Lehmann, J., 1984, Presynaptic receptors on catecholamine neurons, in: Catecholamine II (U. Trendelenburg and N. Weiner, eds.), Springer-Verlag, Berlin, Heidelberg, New York (in press).Google Scholar
  32. Langer, S. Z., and Shepperson, N. B., 1982, Recent developments in vascular smooth muscle pharmacology: The postsynaptic α2-adrenoceptor, Trends Pharmacol. Sci. 3:440–444.CrossRefGoogle Scholar
  33. Langer, S. Z., Arbilla, S., and Kamal, L., 1980a, Autoregulation of noradrenaline and dopamine release through presynaptic receptors, in: Neurotransmitters and Their Receptors (U. Z. Littauer, Y. Dudai, I. Silman, V. I. Teichberg, and Z. Vogel, eds.), John Wiley & Sons, New York, pp. 7–21.Google Scholar
  34. Langer, S. Z., Cavero, I., and Massingham, R., 1980b, Recent developments in noradrenergic neurotransmission and its relevance to the mechanism of action of certain antihypertensive agents, Hypertension 2:372–382.CrossRefGoogle Scholar
  35. Langer, S. Z., Arbilla, S., Kamal, L., and Cantrill, R., 1983a, Peripheral and central dopamine receptors modulating the release of neurotransmitters. Acta Pharm. Suec. SuppL 1 (A. Carlsson and J. L. G. Nilsson, eds), Swedish Pharmaceutical Press, Stockholm, pp. 108–117.Google Scholar
  36. Langer, S. Z., Arbilla, S., Galzin, A. M., and Cantrill, R., 1983b, Stereoselective blockade by Sulpiride or the effects of dopamine agonists on the release of dopamine, noradrenaline and acetylcholine, in: Special Aspects of Psychopharmacology (M. Ackenheil and N. Matrssek, eds.), Expansion Scientifique Françhise, Paris, pp. 103–111.Google Scholar
  37. Lehmann, J., and Langer, S. Z., 1983, Dopamine receptors modulating striatal cholinergic function: A valid model for the postsynaptic actions of dopamine? Neuroscience, 10: 1105–1120.PubMedCrossRefGoogle Scholar
  38. Lehmann, J., Arbilla, S., and Langer, S. Z., 1981, Dopamine receptor mediated inhibition by pergolide of electrically-evoked 3H-dopamine release from striatal slices of cat and rat: slight effect of ascorbate, Naunyn Schmiedebergs Arch. Pharmacol. 317:31–35.PubMedCrossRefGoogle Scholar
  39. Lehmann, J., Smith, R. V., and Langer, S. Z., 1983a, Stereoisomers of apomorphine differ in affinity and intrinsic activity at presynaptic dopamine receptors modulating (3H)-dopamine and (3H)-acetylcholine release in slices of cat caudate, Eur. J. Pharmacol., 88:81–88.CrossRefGoogle Scholar
  40. Lehmann, J., Briley, M., and Langer, S. Z., 1983b, Characterization of classical and novel dopamine receptor agonists at dopamine autoreceptor and 3H-spiperone binding sites in vitro, Eur. J. Pharmacol, 88:11–26.CrossRefGoogle Scholar
  41. Lehmann, J., Lee, C, and Langer, S. Z., 1983c, Dopamine receptors modulating-acetylcholine release in slices of the cat caudate: effects of (-)-N-(2-chloroethyl)-norapomorphine, Eur. J. Pharmacol., 90:393–400.CrossRefGoogle Scholar
  42. Massingham, R., Dubocovich, M. L., and Langer, S. Z., 1980, The role of presynaptic receptors in the cardiovascular action of N,N-di-n-propyldopamine in the cat and dog, Naunyn Schmiedebergs Arch. Pharmacol. 314:17–28.PubMedCrossRefGoogle Scholar
  43. McGeer, E. G., Innanen, V. T., and McGeer, P. L., 1976, Evidence on the cellular localization of adenylcyclase in the neostriatum, Brain Res. 118:356–358.PubMedCrossRefGoogle Scholar
  44. Mitchell, P. R., and Doggett, N. S., 1980, Modulation of striatal [3H]-glutamic acid release by dopaminergic drugs, Life Sci. 26:2073–2081.PubMedCrossRefGoogle Scholar
  45. Nilsson, L. J. G., and Carlsson, A., 1982, Dopamine-receptor agonist with apparent selectivity for autoreceptors: A new principle for antipsychotic action? Trends Pharmacol. Sci. 3:322–325.CrossRefGoogle Scholar
  46. Paul, S. M., Hulihan-Giblin, B., and Skolnick, P., 1982, (+)Amphetamine binding to rat hypothalamus: Relation to anorexic potency of phenyl ethylamines, Science 218:487–490.PubMedCrossRefGoogle Scholar
  47. Pellmar, T. C, 1981, Transmitter control of voltage-dependent currents, Life Sci. 28:2199–2205.CrossRefGoogle Scholar
  48. Reubi, J. C, Iversen, L. L., and Jessell, T. M., 1977, Dopamine selectively increases 3HGABA release from slices of rat substantia nigra in vitro, Nature 268:652–654.PubMedCrossRefGoogle Scholar
  49. Scatton, B., 1982, Effect of dopamine agonists and neurologic agents on striatal acetylcholine transmission in the rat: Evidence against dopamine receptor multiplicity, Pharmacol. Exp. Ther. 220:197–202.Google Scholar
  50. Seeman, P., 1980, Brain dopamine receptors, Pharmacol. Rev. 32:229–313.PubMedGoogle Scholar
  51. Shepperson, N. B., Duval, N., and Langer, S. Z., 1982a, Dopamine decreases mesenteric blood flow in the anaesthetized dog through the Stimulation of postsynaptic α2-adrenoceptors, Eur. J. Pharmacol. 81:627–635.CrossRefGoogle Scholar
  52. Shepperson, N. B., Duval, N., Massingham, R., and Langer, S. Z., 1982b, Differential blocking effects of several dopamine receptor antagonists for peripheral pre-and postsynaptic dopamine receptors in the anaesthetized dog, J. Pharmacol. Exp. Ther. 221:753–761.Google Scholar
  53. Starke, K., Reimann, W., Zumstein, A., and Hertting, G., 1978, Effect of dopamine receptor agonists and antagonists on the release of dopamine in the rabbit caudate nucleus in vitro, Naunyn Schmiedebergs Arch. Pharmacol. 305:27–36.PubMedCrossRefGoogle Scholar
  54. Strömbom, U., 1976, Catecholamine receptor agonists: Effects on motor activity and rate of tyrosine hydroxylation in mouse brain, Naunyn Schmiedebergs Arch. Pharmacol. 292:167–176.PubMedCrossRefGoogle Scholar
  55. Tsuruta, K., Frey, E. A., Grewe, C. W., Cote, T. E., Eskay, R. L., and Kebabian, J. W., 1981, Evidence that LY-141865 speeifieally stimulates the D-2 dopamine receptor, Nature 292:463–466.PubMedCrossRefGoogle Scholar
  56. Voith, K., 1980, Supersensitivity to apomorphine in experimentally induced hypokinesia and drug-induced modifications of the apomorphine response, Psychopharmacology 79:247–254.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • Salomon Z. Langer
    • 1
  • Sonia Arbilla
    • 1
  1. 1.Department of BiologyLaboratoires d’Etudes et de Recherches SynthélaboParisFrance

Personalised recommendations